Plasma levels of N-3 polyunsaturated fatty acids and cognitive decline: Possible role of depressive symptoms and apolipoprotein e genotyping

Journal of the American Geriatrics Society

Volumn 58, Issue 11, 2010, Pages 2249-2251

  Panza, Francesco ^a   Frisardi, Vincenza ^b   Seripa, Davide ^a   Pilotto, Alberto ^a   Solfrizzi, Vincenzo ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; PLACEBO;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FATTY ACID BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HETEROZYGOTE; HUMAN; LETTER; LOW DRUG DOSE; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; NUTRITIONAL ASSESSMENT; RISK REDUCTION; VISUAL MEMORY; WORKING MEMORY;

AGED; APOLIPOPROTEINS E; COGNITION DISORDERS; DEPRESSION; FATTY ACIDS, OMEGA-3; GENOTYPE; HUMANS;

EID: 78449299433     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03110.x     Document Type: Letter

References (13)

1. Solfrizzi V, Frisardi V, Capurso C, et al,. Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms. Ageing Res Rev 2010; 9: 184-199.
2. Cunnane SC, Plourde M, Pifferi F, et al,. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009; 48: 239-256.
3. Panza F, Capurso C, D'Introno A, et al,. Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J Alzheimers Dis 2009; 17: 7-31.
4. Samieri C, Feart C, Letenneur L, et al,. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 2008; 88: 714-721.
5. Samieri C, Féart C, Proust-Lima C, et al,. Omega-3 fatty acids and cognitive decline: Modulation by ApoE epsilon4 allele and depression. Neurobiol Aging 2010. [E-pub ahead of print]; doi: DOI: 10.1016/j.neurobiolaging.2010.03. 020.
6. Panza F, Frisardi V, Capurso C, et al,. Late-life depression, mild cognitive impairment, and dementia: Possible continuum? Am J Geriatr Psychiatry 2010; 18: 98-116.
7. Freeman MP, Hibbeln JR, Wisner KL, et al,. Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006; 67: 1954-1967.
8. Lin PY, Su KP., A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68: 1056-1061.
9. Rubin J, Berglund L., Apolipoprotein E and diets: A case of gene-nutrient interaction? Curr Opin Lipidol 2002; 13: 25-32.
10. Bunce D, Kivipelto M, Wahlin A., Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older. Neuropsychology 2004; 18: 362-370.
11. Freund-Levi Y, Basun H, Cederholm T, et al,. Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 2008; 23: 161-169.
12. Van De Rest O, Geleijnse JM, Kok FJ, et al,. Effect of fish-oil supplementation on mental well-being in older subjects: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2008; 88: 706-713.
13. Van De Rest O, Geleijnse JM, Kok FJ, et al,. Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology 2008; 71: 430-438.